Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 5, 2005, Pages 1251-1256

  Skibola, Danica R ^a   Smith, Martyn T ^a   Bracci, Paige M ^b   Hubbard, Alan E ^a   Agana, Luz ^a   Chi, Shawn ^a   Holly, Elizabeth A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE STIMULANT; CYTOKINE; GHRELIN; LEPTIN; LEPTIN RECEPTOR; NEUROPEPTIDE Y;

ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; DISEASE ASSOCIATION; FOLLICULAR LYMPHOMA; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; APPETITE; CALIFORNIA; CASE-CONTROL STUDIES; DNA PRIMERS; ENERGY METABOLISM; FEMALE; GENOTYPE; HOMEOSTASIS; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUROPEPTIDE Y; OBESITY; PEPTIDE HORMONES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 18544386095     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0895     Document Type: Article

References (39)

1. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62.
2. Fumelli P, Boemi M, Romagnoli F, et al. Influence of body mass on glycemic control in a type 2 diabetic population: a 3-year follow-up. Arch Gerontol Geriatr 2000;30:1-5.
3. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004;23:6365-78.
4. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004;159:259-68.
5. Cerhan JR, Janney CA, Vachon CM, et al. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002; 156:527-35.
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
7. Skibola CF, Holly EA, Forrest MS, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:779-86.
8. Kalra SP, Kalra PS. Neuropeptide Y: A physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2003;22:49-56.
9. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 2004;55:137-54.
10. Ukkola O, Ravussin E, Jacobson P, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002;10:782-91.
11. Hinney A, Hoch A, Geller F, et al. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 2002;87:2716.
12. Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 2003;134:1-11.
13. Kallio J, Pesonen U, Jaakkola U, Karvonen MK, Helenlus H, Koulu M. Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the preproneuropeptide Y. J Clin Endocrinol Metab 2003;88:3278-83.
14. Ding B. Distribution of the NPY 1128C allele frequency in different populations. J Neural Transm 2003;110:1199-204.
15. Ukkola O, Kesaniemi YA. Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus. J Intern Med 2003;254:391-4.
16. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-9.
17. Holly EA, Bracci PM. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. Am J Epidemiol 2003;158:316-27.
18. Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:211-22.
19. Holly EA, Lele C, Bracci P. Non-Hodgkin's lymphoma in homosexual men in the San Francisco Bay Area: occupational, chemical, and environmental exposures. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:223-31.
20. Holly EA, Lele C, Bracci PM. Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco bay area. Am J Public Health 1998;88:1767-73.
21. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999;150:375-89.
22. Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999;26:1676-80.
23. Holly EA, Gautam M, Bracci PM. Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann Epidemiol 2002;12:419-25.
24. LeIe C, Holly EA, Roseman DS, Thomas DB. Comparison of control subjects recruited by random digit dialing and area survey. Am J Epidemiol 1994; 140:643-8.
25. Olson SH, Kelsey JL, Pearson TA, Levin B. Evaluation of random digit dialing as a method of control selection in case-control studies. Am J Epidemiol 1992;135:210-22.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (methodological). 1995;57:289-399.
27. Zhao JH, Lissarrague S, Essioux L, Sham PC. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 2002;18:1694-5.
28. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
29. Schwarz H, Villiger PM, von Kempis J, Lotz M. Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 1994;51: 53-61.
30. Zukowska Z, Pons J, Lee EW, Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 2003;81:89-94.
31. Nair MP, Schwarte SA, Wu K, Kronfol Z. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun 1993;7: 70-8.
32. Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 1991;5:3100-7.
33. Kawamura N, Tamura H, Obana S, et al. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998;5:9-15.
34. Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG. Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma. Am J Epidemiol 2003;157:510-6.
35. Barreca A, Valli B, Cesarone A, et al. Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture. Fertil Steril 1998;70:320-5.
36. McMurray RW. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol 2001;1:995-1008.
37. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004;114:57-66.
38. Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the third national health and nutrition examination survey, 1988-1994. J Am Diet Assoc 2001;101:28-34; quiz 35-6.
39. Kraft P, Cox DG, Paynter RA, Hunter D, De Vivo I. Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques. Genet Epidemiol 2005;28:261-72.